Dr. Terrie Mendelson, MD

Dr. Mendelson practices at UCSF St Mary's Hospital in San Francisco, California.

Dr. Mendelson's NPI, 1871647347, was assigned on January 22, 2007. Dr. Mendelson graduated from UCSF School of Medicine in 1984. Dr. Mendelson holds California license G57295.

Dr. Mendelson's primary practice is UCSF St Mary's Hospital, at 450 Stanyan St, San Francisco, CA 94117 in San Francisco County. The practice phone is (415) 353-4739.

Dr. Mendelson's primary practice is UCSF St Mary's Hospital in San Francisco, California. Dr. Mendelson is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Mendelson to 1 more hospital and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mendelson practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Mendelson's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Mendelson is board certified in internal medicine by the American Board of Internal Medicine. Dr. Mendelson is licensed in California.

Dmand AI lists acute diabetes, acute respiratory failure, acute skin infection, aneurysm, arthritis, chronic anemia, chronic diabetes and chronic hypertension among the conditions Dr. Mendelson treats.

CMS data shows 243 Medicare services from Dr. Mendelson across 6 procedure codes in 2024, for 148 Medicare patients. Medicare paid $21,442 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 148 Medicare patients who saw Dr. Mendelson in 2024. The largest group is 65 to 74, with 59 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 80% are also on Medicaid. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mendelson's median patient age at 74, with 51% women.

In 2024, Dr. Mendelson wrote 377 Medicare Part D claims for 94 patients. 86% of them were for generic drugs. CMS names the drug for 118 of them, across 4 drugs with 11 or more claims each, at $888 in total drug cost. In 2023, CMS named 85 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Mendelson for performance year 2024, reported as part of a group. Dr. Mendelson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mendelson as offering telehealth.

Dmand AI links 5 papers to Dr. Mendelson. The most frequent topics are Audiometry, Evoked Response, Brain Stem and Evoked Potentials, Auditory. Dr. Mendelson has published most often in Audiology. Dr. Mendelson's most frequent co-author is William Tooley, MD.

CMS Open Payments shows 112 general payments to Dr. Mendelson from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $1,205.

Dmand AI lists 3 awards for Dr. Mendelson, most recently Excellence in Teaching and Mentorship Award in 2015.

Dr. Mendelson graduated from UCSF School of Medicine in 1984. Dr. Mendelson is a member of Accreditation Council for Graduate Medical Education, AAIM, AOA, ACP and SHM.

Dr. Mendelson is in network with 4 carriers, including United Healthcare, Blue Cross and Blue Shield of Kansas City and CMS Medicare. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.